Decipher Labs Limited, together with its subsidiaries, manufactures, markets, sells, and trades in pharmaceutical drugs in India and internationally. It operates through Pharmaceutical and Consultancy segments. The company offers branded and finished formulations, bulk drugs, and chemicals. It also provides information technology (IT) consultancy services comprising technology integration and systems consulting, software development consulting, and management of IT projects. In addition, the company offers ERP implementation, mobile and cloud solutions, product development, and offshore services. It serves formulators, manufacturers, and research and development agencies. The company was formerly known as Combat Drugs Limited and changed its name to Decipher Labs Limited in January 2020. Decipher Labs Limited was incorporated in 1986 and is based in Hyderabad, India.
| Current Price | ₹7.50 |
|---|---|
| Market Cap | ₹8 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | -2.5 |
| Return on Equity | -14.17% |
| 52-Week Range | ₹5.00 – ₹11.95 |
| Beta (1Y) | 1.07 |
Decipher Labs Ltd is trading at ₹7.50, with a market capitalisation of ₹8 Cr.
Decipher Labs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Decipher Labs Ltd has a P/E of -2.5 and a return on equity of -14.17%.